Summary
The effect of triptolide (TP) on the expression of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) was explored in rat adjuvant induced arthritis (AA). AA was induced in Wistar rats. Arthritis rats were treated with TP and methotrexate (MTX) at the onset (day 9) of arthritis. On the peak of arthritis (day 24), the expression of RANKL and OPG protein in the joints and RANKL mRNA in peripheral blood mononuclear cells (PBMC) was detected. TNF-α and IL-1β levels in peripheral blood were determined. Bone erosion scores were also evaluated. The results showed that bone erosion scores in TP and MTX groups were lower than in AA group (P<0.01); The expression levels of RANKL in the synovium (P<0.01) and bone (P<0.05), and OPG level in synovium (P<0.05) were lower in TP group than in AA group (P<0.05). In TP group, the expression levels of RANKL mRNA and TNF-α, IL-1β in PBMC were lower than in AA group (allP<0.01). It was concluded that TP could inhibit rat adjuvant arthritis bone erosion by suppressing the expression of RANKL.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hu Y H, Weng G M, Lu F Eet al. Experimental investigation on triptolide induced apoptosis of synoviocytes in collagen induced arthritis rat. Chin J Rheumatology (Chinese), 2004, 8: 131–134
Bolon B, Campagnuolo G, Feige U. Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis. Cell Mol Life Sci, 2002, 59: 1569–1576
Dai S M, Shan Z Z, Han X H. Pathogenesis of bone erosion in rheumatoid arthritis. Chin J Rheumatology (Chinese), 2002, 6: 201–203
Dequeker J, Maenaut K, Verwilghen Jet al. Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol, 1995, 13(Suppl. 12): S21-S26
Gough A, Sambrook P, Devlin Jet al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol, 1998, 25: 1282–1289
Saidenberg-Kermanach N, Cohen-Solal M, Bessis Net al. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine, 2004, 71: 9–13
Miyashita T, Kawakami A, Nakashima Tet al. Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. Clin Exp Immunol, 2004, 137: 430–436
Dai S M, Nishioka K, Yudoh K. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumor necrosis factor alpha. Ann Rheum Dis, 2004, 63: 1379–1386
Author information
Authors and Affiliations
Additional information
HU Yonghong, female, born in 1953, Professor
This project was supported by a grant from National Natural Sciences Foundation of China (No. 30070961).
Rights and permissions
About this article
Cite this article
Yonghong, H., Bo, L., Mingmin, Z. et al. Effect of triptolide on expression of receptor activator of nuclear factor-κB ligand in rat adjuvant induced arthritis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 26, 344–346 (2006). https://doi.org/10.1007/BF02829571
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02829571